Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221679 | 1.00 | TSHR (0.43) | TSHRTP53LMNAF2ALDH1A1 | |
| SCHEMBL27362899 | 1.00 | TSHR (0.43) | TSHRTP53LMNAF2ALDH1A1 | |
| SCHEMBL7686 | 1.00 | TSHR (0.43) | TSHRTP53LMNAF2ALDH1A1 | |
| SCHEMBL2904556 | 1.00 | TSHR (0.43) | TSHRTP53LMNAF2ALDH1A1 | |
| SCHEMBL1483657 | 1.00 | TSHR (0.43) | TSHRTP53LMNAF2ALDH1A1 | |
| SCHEMBL3946464 | 0.98 | TSHR (0.42) | TSHRTP53LMNAF2ALDH1A1 | |
| Water SCHEMBL1818831 | 0.98 | TSHR (0.42) | TSHRTP53LMNAF2ALDH1A1 | |
| Water SCHEMBL789812 | 0.98 | TSHR (0.42) | TSHRTP53LMNAF2ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL11444698 | 0.98 | TSHR (0.42) | TSHRTP53LMNAF2ALDH1A1 | |
| SCHEMBL11542849 | 0.98 | TSHR (0.42) | TSHRTP53LMNAF2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1773 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132108-A1 | PREPARATION OF MESEMBRINE | KANNA HEALTH LTD (GB) | 2026-05-14 | — | — | US | claimed |
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | KURA ONCOLOGY INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4720073-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | Kura Oncology, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4598904-A1 | PREPARATION OF MESEMBRINE | Kanna Health Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| US-20250215005-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-07-03 | — | — | US | claimed |
| WO-2025133917-A1 | PROCESS FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5- ETHOXY-1, 4-DIHYDRO-2,8-DIMETHYL-1,6-NAPTHYRIDINE-3-CARBOXAMIDE | INDUSTRIALE CHIMICA S.R.L. (IT) | 2025-06-26 | — | — | WO | claimed |
| US-20250115601-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-04-10 | — | — | US | claimed |
| EP-4525877-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | Alivus Life Sciences Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| EP-4526302-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | Alivus Life Sciences Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| US-12247030-B2 | Process for preparing compositions comprising an enantiomeric excess of a substituted pyrrolo[2,3-d]pyrimidine | INCYTE HOLDINGS CORPORATION (US) | 2025-03-11 | — | — | US | claimed |
| EP-0438796-A2 | Process for the enantioselection synthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-07-31 | — | — | EP | claimed |
| WO-1991004253-A1 | PREPARATION OF S-(-)- AND R-(+)-N-(QUINUCLIDINYL-3)-AMIDE | CHIRON LABORATORIES A.S (NO) | 1991-04-04 | — | — | WO | claimed |
| EP-0420120-A2 | Optically active benzyl alcohol compound and pharmaceutical composition | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1991-04-03 | — | — | EP | claimed |
| EP-0418770-A2 | Process for the chemical resolution of 5-alkoxy-substituted (+/-)-1,3-dimethyloxindolylethylamines | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-03-27 | — | — | EP | claimed |
| EP-0107825-B1 | 1,3,4,6,7,11B-HEXAHYDRO-7-ARYL-2H-PYRAZINO (2,1-ALPHA) ISOQUINOLINES USEFUL AS INTERMEDIATES AND PHARMACEUTICAL COMPOUNDS AND METHODS OF PREPARATION | PENNWALT CORPORATION (US) | 1988-03-02 | — | — | EP | claimed |
| EP-0092787-B1 | PROCESS FOR THE PREPARATION OF A PHENYLALKYLAMINOETHYLSALICYLAMIDE | SCHERING CORPORATION (US) | 1986-08-27 | — | — | EP | claimed |
| EP-0107825-A1 | 1,3,4,6,7,11b-Hexahydro-7-aryl-2H-pyrazino (2,1-alpha) isoquinolines useful as intermediates and pharmaceutical compounds and methods of preparation | PENNWALT CORPORATION (US) | 1984-05-09 | — | — | EP | claimed |
| EP-0092787-A1 | Process for the preparation of a phenylalkylaminoethylsalicylamide | SCHERING CORPORATION (US) | 1983-11-02 | — | — | EP | claimed |
| US-4370500-A | Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization | AMERICAN CYANAMID COMPANY (US) | 1983-01-25 | — | — | US | claimed |
| EP-0010851-A2 | Process for the preparation of tetramisole | AMERICAN CYANAMID COMPANY (US) | 1980-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | FDPS, PCTP, MTTP | TSHR 595/4885TP53 116/4885LMNA 3952/4885 |
| US-12247030-B2 | Process for preparing compositions comprising an enantiomeric excess of a substituted pyrrolo[2,3-d]pyrimidine | DPYD, TYMS, TYMP | TSHR 4626/4885TP53 1234/4885LMNA 2873/4885 |
| US-20260132108-A1 | PREPARATION OF MESEMBRINE | BHMT, TMSB10, MSMO1 | TSHR 4332/4885TP53 4739/4885LMNA 768/4885 |
| US-20250215005-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | JAK2, JAK3, JAK1 | TSHR 1759/4885TP53 1538/4885LMNA 4371/4885 |
| US-20250115601-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | CYP17A1, HSD17B7, CYP11B1 | TSHR 2799/4885TP53 4116/4885LMNA 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.